Literature DB >> 26070485

DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

Patricia Conde1, Mercedes Rodriguez2, William van der Touw3, Ana Jimenez3, Matthew Burns1, Jennifer Miller3, Manisha Brahmachary4, Hui-ming Chen3, Peter Boros5, Francisco Rausell-Palamos6, Tae Jin Yun7, Paloma Riquelme8, Alberto Rastrojo9, Begoña Aguado9, Joan Stein-Streilein10, Masato Tanaka11, Lan Zhou12, Junfeng Zhang13, Todd L Lowary13, Florent Ginhoux14, Chae Gyu Park15, Cheolho Cheong7, Joshua Brody3, Shannon J Turley16, Sergio A Lira17, Vincenzo Bronte18, Siamon Gordon19, Peter S Heeger1, Miriam Merad3, James Hutchinson8, Shu-Hsia Chen3, Jordi Ochando20.   

Abstract

Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T cell immunity and promoted CD4(+)Foxp3(+) Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages in vivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26070485      PMCID: PMC4690204          DOI: 10.1016/j.immuni.2015.05.009

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

1.  DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production.

Authors:  Esther Caparrós; Pilar Munoz; Elena Sierra-Filardi; Diego Serrano-Gómez; Amaya Puig-Kröger; José L Rodríguez-Fernández; Mario Mellado; Jaime Sancho; Mercedes Zubiaur; Angel L Corbí
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

2.  Absence of innate MyD88 signaling promotes inducible allograft acceptance.

Authors:  Wendy E Walker; Isam W Nasr; Geoffrey Camirand; Bethany M Tesar; Carmen J Booth; Daniel R Goldstein
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

3.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

4.  C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.

Authors:  Sonja I Gringhuis; Jeroen den Dunnen; Manja Litjens; Bert van Het Hof; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  Immunity       Date:  2007-04-26       Impact factor: 31.745

5.  Specificity of DC-SIGN for mannose- and fucose-containing glycans.

Authors:  Ellis van Liempt; Christine M C Bank; Padmaja Mehta; Juan Jesús Garciá-Vallejo; Ziad S Kawar; Rudolf Geyer; Richard A Alvarez; Richard D Cummings; Yvette van Kooyk; Irma van Die
Journal:  FEBS Lett       Date:  2006-10-16       Impact factor: 4.124

6.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection.

Authors:  Y Huang; H Yin; J Han; B Huang; J Xu; F Zheng; Z Tan; M Fang; L Rui; D Chen; S Wang; X Zheng; C-Y Wang; F Gong
Journal:  Am J Transplant       Date:  2007-02-28       Impact factor: 8.086

8.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

10.  Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens.

Authors:  Yasunobu Miyake; Kenichi Asano; Hitomi Kaise; Miho Uemura; Manabu Nakayama; Masato Tanaka
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more
  68 in total

1.  Transplant tolerance: a new role for IL-34.

Authors:  James I Kim; Laurence A Turka
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

2.  New insights into the multidimensional concept of macrophage ontogeny, activation and function.

Authors:  Florent Ginhoux; Joachim L Schultze; Peter J Murray; Jordi Ochando; Subhra K Biswas
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 3.  Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.

Authors:  Joseph R Scalea; Young Suk Lee; Eduardo Davila; Jonathan S Bromberg
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity.

Authors:  Jordi Ochando; Patricia Conde
Journal:  J Vis Exp       Date:  2017-06-07       Impact factor: 1.355

5.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

6.  Engineered immune cells as highly sensitive cancer diagnostics.

Authors:  Amin Aalipour; Hui-Yen Chuang; Surya Murty; Aloma L D'Souza; Seung-Min Park; Gunsagar S Gulati; Chirag B Patel; Corinne Beinat; Federico Simonetta; Ivana Martinić; Gayatri Gowrishankar; Elise R Robinson; Eamon Aalipour; Zahra Zhian; Sanjiv S Gambhir
Journal:  Nat Biotechnol       Date:  2019-03-18       Impact factor: 54.908

7.  Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.

Authors:  C Wu; Y Zhao; X Xiao; Y Fan; M Kloc; W Liu; R M Ghobrial; P Lan; X He; X C Li
Journal:  Am J Transplant       Date:  2016-05-02       Impact factor: 8.086

8.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

Review 9.  Acute and chronic phagocyte determinants of cardiac allograft vasculopathy.

Authors:  Kristofor Glinton; Matthew DeBerge; Xin-Yi Yeap; Jenny Zhang; Joseph Forbess; Xunrong Luo; Edward B Thorp
Journal:  Semin Immunopathol       Date:  2018-08-23       Impact factor: 9.623

10.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

Authors:  Ilaria Marigo; Serena Zilio; Giacomo Desantis; Bernhard Mlecnik; Andrielly H R Agnellini; Stefano Ugel; Maria Stella Sasso; Joseph E Qualls; Franz Kratochvill; Paola Zanovello; Barbara Molon; Carola H Ries; Valeria Runza; Sabine Hoves; Amélie M Bilocq; Gabriela Bindea; Emilia M C Mazza; Silvio Bicciato; Jérôme Galon; Peter J Murray; Vincenzo Bronte
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.